PDC and bronchopulmonary dysplasia: Inhibition of HIF PHD during hyperoxia exposure with inhibitory analogues of α-ketoglutarate cofactor to HIF PHD, such as dimethyloxalylglycine (DMOG) or Roxadustat (FG-4592), prevents catabolism of HIF and was previously shown to induce protection against both oxygen-induced retinopathy (OIR) and BPD [24,25].